DOCSF 2023: DOCSF Venture Summary

We are delighted to welcome back Nancy Lynch, MD, MBA to our show, where she will be sharing insights on investment and innovation in the MSK (musculoskeletal) space.

Dr. Lynch highlights that a significant portion of recent investments has been directed towards ortho-facilitated ancillary technologies, with an impressive 75% of these investments being AI-based. She also addresses the impact of the collapse of Silicon Valley Bank on startup financing, emphasizing that it is relatively inconsequential compared to other factors. Venture capitalists are now adopting a more discerning approach to new investments, prioritizing solid business models. Moreover, the prolonged period of uncertainty, global and political issues, market volatility, and the looming possibility of a recession are presenting formidable challenges for startups.

Tune in to gain valuable insights and recommendations for navigating the potential upcoming period of consolidation and challenges in the world of venture capital.